Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3960553
Max Phase: Preclinical
Molecular Formula: C45H48Cl2F2N6O5S
Molecular Weight: 893.88
Molecule Type: Small molecule
Associated Items:
ID: ALA3960553
Max Phase: Preclinical
Molecular Formula: C45H48Cl2F2N6O5S
Molecular Weight: 893.88
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4cnc(OCC5CCC(F)(F)CC5)c(Cl)c4)c(Oc4cccc5[nH]cnc45)c3)CC2)=C(c2ccc(Cl)cc2)C1
Standard InChI: InChI=1S/C45H48Cl2F2N6O5S/c1-44(2)15-14-31(36(24-44)30-6-8-32(46)9-7-30)26-54-18-20-55(21-19-54)33-10-11-35(40(22-33)60-39-5-3-4-38-41(39)52-28-51-38)42(56)53-61(57,58)34-23-37(47)43(50-25-34)59-27-29-12-16-45(48,49)17-13-29/h3-11,22-23,25,28-29H,12-21,24,26-27H2,1-2H3,(H,51,52)(H,53,56)
Standard InChI Key: VVVAKMPZNXONCI-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 893.88 | Molecular Weight (Monoisotopic): 892.2752 | AlogP: 10.17 | #Rotatable Bonds: 12 |
Polar Surface Area: 129.75 | Molecular Species: ACID | HBA: 9 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.13 | CX Basic pKa: 7.95 | CX LogP: 7.71 | CX LogD: 7.86 |
Aromatic Rings: 5 | Heavy Atoms: 61 | QED Weighted: 0.13 | Np Likeness Score: -0.85 |
1. (2015) Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases, |
Source(1):